Inhibitor Therapeutics, Inc. INTI
INTI
Inhibitor Therapeutics, Inc. LIANY
LianBio OXBOF
Oxford BioDynamics Plc DVHGF
Devonian Health Group Inc. CHMMF
Chimeric Therapeutics Limited QNNTF
Quantum Genomics S.A. CUBT
Curative Biotechnology, Inc. NYMXF
Nymox Pharmaceutical Corporation BETRF
BetterLife Pharma Inc. PHRRF
PharmaTher Holdings Ltd.
Inhibitor Therapeutics, Inc. LIANY
LianBio OXBOF
Oxford BioDynamics Plc DVHGF
Devonian Health Group Inc. CHMMF
Chimeric Therapeutics Limited QNNTF
Quantum Genomics S.A. CUBT
Curative Biotechnology, Inc. NYMXF
Nymox Pharmaceutical Corporation BETRF
BetterLife Pharma Inc. PHRRF
PharmaTher Holdings Ltd.
Performance
| Periode | INTI | LIANY | OXBOF | DVHGF | CHMMF | QNNTF | CUBT | NYMXF | BETRF | PHRRF |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 4.65 % | -76.10 % | -65.00 % | -60.50 % | 0.00 % | 0.00 % | -27.22 % | -11.72 % | -39.42 % | -69.48 % |
| YTD | -30.77 % | -64.29 % | -86.00 % | -46.34 % | 0.00 % | 0.00 % | -44.26 % | -31.05 % | -45.19 % | -51.90 % |
| 1Y | -31.35 % | -62.29 % | -86.00 % | -46.34 % | 0.00 % | 0.00 % | -45.86 % | -50.75 % | -45.58 % | -52.40 % |
| 3Y | -54.55 % | -93.99 % | -99.29 % | -71.56 % | -98.33 % | -97.06 % | -57.00 % | -79.11 % | -66.00 % | 48.00 % |
| 5Y | 18.42 % | -99.28 % | -99.88 % | -82.57 % | -98.46 % | -98.20 % | -73.96 % | -97.03 % | -96.81 % | -68.84 % |
| 10Y | -63.41 % | -99.28 % | -99.88 % | -82.57 % | -98.46 % | -98.20 % | -49.83 % | -97.98 % | -99.59 % | -58.87 % |
| From the beginning | -99.70 % | -99.28 % | -99.88 % | -82.57 % | -98.46 % | -98.20 % | -100.00 % | -98.94 % | -99.98 % | -58.87 % |